CLDX Quote, Trading Chart, Celldex Therapeutics Inc.
home / stock / cldx / cldx quote
$28.25 Last:
1.69% Change Percent:
$28.13 Open:
$28.25 Previous Close:
$29.105 High:
$27.8 Low:
443,540 Volume:
06/21/2021 04:42:45 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CLDX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 28.13 | 28.25 | 29.105 | 27.8 | 443,540 |
| 2021-06-18 | 27.71 | 27.78 | 28.39 | 26.8042 | 1,192,378 |
| 2021-06-17 | 27.9 | 28 | 29.303 | 26.75 | 417,296 |
| 2021-06-16 | 29.24 | 27.79 | 29.585 | 27.56 | 348,994 |
| 2021-06-15 | 30.82 | 29.2 | 30.82 | 28.96 | 283,389 |
| 2021-06-14 | 31.04 | 30.64 | 31.16 | 30.3 | 444,263 |
| 2021-06-11 | 30.18 | 31.04 | 31.06 | 30.07 | 451,114 |
| 2021-06-10 | 30.05 | 30.56 | 30.74 | 29.6604 | 315,735 |
| 2021-06-09 | 29.66 | 30.05 | 30.33 | 29.4 | 405,576 |
| 2021-06-08 | 28.5 | 29.65 | 29.825 | 28.1 | 643,730 |
| 2021-06-07 | 27.67 | 28.5 | 28.96 | 27.6 | 746,392 |
| 2021-06-04 | 28.31 | 27.91 | 28.695 | 27.12 | 203,918 |
| 2021-06-03 | 28.05 | 28.07 | 28.76 | 27.71 | 240,957 |
| 2021-06-02 | 27.93 | 28.01 | 28.155 | 27.22 | 488,357 |
| 2021-06-01 | 27.95 | 27.78 | 28.34 | 26.995 | 286,677 |
| 2021-05-31 | 28.44 | 27.95 | 29.2366 | 27.9 | 234,337 |
| 2021-05-28 | 28.44 | 27.95 | 29.2366 | 27.9 | 234,337 |
| 2021-05-27 | 27.68 | 28.25 | 28.27 | 27.6 | 426,953 |
| 2021-05-26 | 26.5 | 27.54 | 27.54 | 26.44 | 263,047 |
| 2021-05-25 | 27.04 | 26.39 | 27.48 | 26.26 | 296,714 |
Celldex Therapeutics Inc. Company Name:
CLDX Stock Symbol:
NASDAQ Market:
Celldex Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
HAMPTON, N.J., June 04, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced preliminary data from the Company’s Phase 1 dose escalation study of PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies. These data were presented in a...
-
HAMPTON, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing results from the Phase 1b study of CDX-0159 in patients with antihistamine refractory cold contact urticaria (ColdU) and symptomatic dermographism (SD), the ...
-
HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30 p.m. ET. A webcast of the presenta...